Abstract

One function ascribed to apoptosis is the suicidal destruction of potentially harmful cells, such as cancerous cells. Hence, their growth depends on evasion of apoptosis, which is considered as one of the hallmarks of cancer. Apoptosis is ultimately carried out by the sequential activation of initiator and executioner caspases, which constitute a family of intracellular proteases involved in dismantling the cell in an ordered fashion. In cancer, therefore, one would anticipate caspases to be frequently rendered inactive, either by gene silencing or by somatic mutations. From clinical data, however, there is little evidence that caspase genes are impaired in cancer. Executioner caspases have only rarely been found mutated or silenced, and also initiator caspases are only affected in particular types of cancer. There is experimental evidence from transgenic mice that certain initiator caspases, such as caspase-8 and -2, might act as tumor suppressors. Loss of the initiator caspase of the intrinsic apoptotic pathway, caspase-9, however, did not promote cellular transformation. These data seem to question a general tumor-suppressive role of caspases. We discuss several possible ways how tumor cells might evade the need for alterations of caspase genes. First, alternative splicing in tumor cells might generate caspase variants that counteract apoptosis. Second, in tumor cells caspases might be kept in check by cellular caspase inhibitors such as c-FLIP or XIAP. Third, pathways upstream of caspase activation might be disrupted in tumor cells. Finally, caspase-independent cell death mechanisms might abrogate the selection pressure for caspase inactivation during tumor development. These scenarios, however, are hardly compatible with the considerable frequency of spontaneous apoptosis occurring in several cancer types. Therefore, alternative concepts might come into play, such as compensatory proliferation. Herein, apoptosis and/or non-apoptotic functions of caspases may even promote tumor development. Moreover, experimental evidence suggests that caspases might play non-apoptotic roles in processes that are crucial for tumorigenesis, such as cell proliferation, migration, or invasion. We thus propose a model wherein caspases are preserved in tumor cells due to their functional contributions to development and progression of tumors.

Highlights

  • One function ascribed to apoptosis is the suicidal destruction of potentially harmful cells, such as cancerous cells

  • There are several scenarios conceivable which may explain this counterintuitive conclusion: (i) Alternative splicing may generate dominant-negative caspase variants; (ii) caspases are blocked by inhibitory proteins; (iii) caspase-activating pathways are abrogated; (iv) caspase-independent cell death (CICD) mechanisms might circumvent the selection against functional caspase genes during tumorigenesis

  • Loss of functional caspases is not a common event in human cancer, and evasion of apoptosis does not seem to represent a general hallmark of cancer

Read more

Summary

Structure and Activation of Caspases

Caspases are the proteases responsible for dismantling the cell in an ordered and histologically distinct process termed apoptosis [1]. Based on protein structure and activation mechanism, caspases can be subdivided into initiator caspases and executioner caspases. The former harbor protein-protein interaction domains at their aminoterminus, either death effector domains (DED) or caspase recruitment domains (CARD). These serve for their recruitment to specific activator platforms, where they become activated by induced proximity. There are four initiator caspases, Caspase-8 and Caspase-10, Caspase-9, and Caspase-2 Upon apoptotic stimuli their proforms are recruited to specific activator platforms. Caspase-9 is activated in a large protein complex termed the apoptosome. Caspase-2 is activated upon genotoxic stress in a large protein complex termed the PIDDosome [5]. Caspase-14 shares the structure with executioner caspases and appears to be involved in skin differentiation [7]

Is loss of Caspase Activity Involved in Cancer?
Somatic Mutations of Caspase Genes in Human Cancer
Executioner caspases
Initiator caspases
Evidence from Transgenic Mice
In Vitro Transformation of Human Cells
Why Caspase Genes Possibly Need Not be Altered in Tumors?
Scenario 1
Scenario 2
Scenario 3
Scenario 4
The Occurrence of Spontaneous Apoptosis in Tumors
Non-Apoptotic Functions of Caspases Possibly Involved in Tumorigenesis
Caspases in Proliferation
Caspases in Migration and Invasion
Findings
Concluding Remarks

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.